Repligen | Ventes



Sales Changement Date
Agilent USD 1.68B 20M 2025-01
Align Technology USD 995.22M 17.35M 2024-12
Bio Techne USD 297.03M 7.57M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Bruker USD 979.6M 115.2M 2024-12
Charles River Laboratories USD 1B 7.21M 2024-12
Danaher USD 6.54B 740M 2024-12
Dentsply International USD 905M 46M 2024-12
Exact Sciences USD 713.42M 4.77M 2024-12
General Electric USD 9.88B 940M 2024-12
Henry Schein USD 3.19B 17M 2024-12
Illumina USD 1.1B 24M 2024-12
IQVIA Holdings USD 3.96B 62M 2024-12
Mettler Toledo International USD 1.05B 95.46M 2024-12
Myriad Genetics USD 210.6M 2.7M 2024-12
Patterson Companies USD 1.57B 101.96M 2025-01
Pfizer USD 17.76B 61M 2024-12
Repligen USD 168M 13M 2024-12
Revvity USD 729.37M 45.32M 2024-12
Standard Biotools USD 46.72M 1.75M 2024-12
Thermo Fisher Scientific USD 11.4B 797M 2024-12
Waters USD 872.71M 132.41M 2024-12
West Pharmaceutical Services USD 748.8M 1.9M 2024-12



Repligen Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.